J&J COVID vaccine is effective against Omicron sub-variants - Sisonke research - EWN

Safety and efficacy data of the Johnson & Johnson COVID-19 vaccine, recently published in the 'New England Journal of Medicine', found that a second dose of the jab offered up to 82% protection.

Safety and efficacy data of the Johnson & Johnson COVID-19 vaccine, recently published in the 'New England Journal of Medicine', found that a second dose of the jab offered up to 82% protection. … [+1248 chars]

full article...